Woodchuck hepatitis virus post-transcriptional regulation element enhances transgene expression from adenovirus vectors

Biochimica et Biophysica Acta - General Subjects

Volumn 1621, Issue 3, 2003, Pages 266-271

  Xu, Zhi Li ^a,b   Mizuguchi, Hiroyuki ^a   Mayumi, Tadanori ^b   Hayakawa, Takao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Adenovirus vector; Gene function; Gene therapy; Transgene expression; Woodchuck hepatitis virus post transcriptional regulation element (WPRE)

Indexed keywords

ADENOVIRUS VECTOR; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENHANCER REGION; FEMALE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC MODEL; HEPATITIS VIRUS; HUMAN; HUMAN CELL; INTRON; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; TRANSGENE;

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS; MARMOTA MONAX; WOODCHUCK HEPATITIS B VIRUS;

EID: 0038699545     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(03)00078-3     Document Type: Article

References (35)

1. Kovesdi I., Brough D.E., Bruder J.T., Wickham T.J. Adenoviral vectors for gene transfer. Curr. Opin. Biotechnol. 8:1997;583-589.
2. Benihoud K., Yeh P., Perricaudet M. Adenovirus vectors for gene delivery. Curr. Opin. Biotechnol. 10:1999;440-447.
3. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1997;1320-1323.
4. Tomko P.R., Xu R., Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U. S. A. 94:1997;:3352-3356.
5. Yang Y., Li Q., Ertl H.C., Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004-2015.
6. Somia N., Verma I.M. Gene therapy: trials and tribulations. Nat. Rev., Genet. 1:2000;91-99.
7. Xu Z.L., Mizuguchi H., Ishii-Watabe A., Uchida E., Mayumi T., Hayakawa T. Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene. 272:2001;149-156.
8. Xu Z.L., Mizuguchi H., Ishii-Watabe A., Uchida E., Mayumi T., Hayakawa T. Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector. J. Control. Release. 81:2002;155-163.
9. Donello J.E., Loeb J.E., Hope T.J. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J. Virol. 72:1998;5085-5092.
10. Loeb J.E., Cordier W.S., Harris M.E., Weitzman M.D., Hope T.J. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. Hum. Gene Ther. 10:1999;2295-2305.
11. Paterna J.C., Moccetti T., Mura A., Feldon J., Bueler H. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther. 7:2000;1304-1311.
12. Moreau-Gaudry F., Xia P., Jiang G., Perelman N.P., Bauer G., Ellis J., Surinya K.H., Mavilio F., Shen C.K., Malik P. High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. Blood. 98:2001;2664-2672.
13. Ramezani A., Hawley T.S., Hawley R.G. Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol. Ther. 2:2000;458-469.
14. Zufferey R., Donello J.E., Trono D., Hope T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73:1999;2886-2892.
15. Schambach A., Wodrich H., Hildinger M., Bohne J., Krausslich H.G., Baum C. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol. Ther. 2:2000;435-445.
16. Mizuguchi H., Kay M.A. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther. 9:1998;2577-2583.
17. Mizuguchi H., Kay M.A. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Hum. Gene Ther. 10:1999;2013-2017.
18. Niwa H., Yamamura K., Miyazaki K.J. Efficient selection for high- expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-199.
19. Kanegae Y., Makimura M., Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Bio. 47:1994;157-166.
20. Heffelfinger S.C., Hawkins H.H., Barrish J., Taylor L., Darlington G.J. SK HEP-1: a human cell line of endothelial origin (1992). In Vitro Cell. Dev. Biol. 28(A):1992;136-142.
21. Asaoka K., Tada M., Sawamura Y., Ikeda J., Abe H. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. J. Neurosurg. 92:2000;1002-1008.
22. Takahashi K., Sawasaki Y., Hata J., Mukai K., Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell. Dev. Biol. 26:1990;265-274.
23. Li S., Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 4:1997;891-900.
24. Steinwaerder D.S., Lieber A. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Ther. 7:2000;556-567.
25. Huard J., Lochmuller H., Acsadi G., Jani A., Massie B., Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2:1995;107-115.
26. Wood M., Perrotte P., Onishi E., Harper M.E., Dinney C., Pagliaro L., Wilson D.R. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther. 6:1999;367-372.
27. Mizuguchi H., Koizumi N., Hosono T., Ishii-WatabeK A., Uchida E., Utoguchi N., Watanabe Y., Hayakawa T. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther. 9:2002;769-776.
28. Yang Y., Nunes F.A., Berencsi K., Gonczoi E., Engelhardt J.F., Wilson J.M. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:1994;362-369.
29. Wang Q., Greenburg G., Bunch D., Farson D., Finer M.H. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Gene Ther. 4:1997;393-400.
30. Lieber A., He C.Y., Kay M.A. Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo. Nat. Biotechnol. 15:1997;1383-1387.
31. Schiedner G., Morral N., Parks R.J., Wu Y., Koopmans S., Langston C., Graham F., Beaudet A., Kochanek S. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18:1998;180-183.
32. Kochanek S. High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum. Gene Ther. 10:1999;2451-2459.
33. Sandig V., Youil R., Bett A.J., Franlin L.L., Oshima M., Maione D., Wang F., Metzker M.L., Savino R., Caskey T. Optimization of the helper- dependent adenovirus system for production and potency in vivo. Proc. Natl. Acad. Sci. U. S. A. 97:2000;1002-1007.
34. Popa I., Harris M.E., Donello J.E., Hope T.J. CRM1-dependent function of a cis-acting RNA export element. Mol. Cell. Biol. 22:2002;2057-2067.
35. Huang Z.M., Yen T.S. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol. Cell. Biol. 15:1995;3864-3869.